| Execution period | Quarter ended 31st March 2026 |
|---|
BSE filing, NSE: TITAGARH. Summary written from the filing by ALFA Finder's alert engine.
Titagarh Rail Systems Ltd: key numbers
- Share price
- ₹669.60
- Market cap
- ₹9,018 Cr
- Revenue (annual)
- ₹3,186 Cr
- Net profit (annual)
- ₹122.8 Cr
- P/E (TTM)
- 47.2×Sector 30.9×
- Promoter holding
- 40.46%+0.00% QoQ
- FII holding
- 11.39%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Titagarh Rail Systems Ltd
All →Titagarh Rail Systems Order Update: ₹1,717 Cr
Titagarh Rail received an additional 4,955 BOXNHL wagon order from the Ministry of Railways, valued at ₹1,716.90 Crore plus GST. The amended contract now totals ₹10,404.10 Crore including GST.
- Value
- ₹1,717 Cr
- From
- Ministry of Railways
- Execution
- 222 days from the amendment date, up to 07.06.2027
Titagarh Rail Systems Board Meeting Date
Titagarh Rail Systems scheduled a board meeting for 29 October 2026 to approve unaudited financial results. The trading window remains closed until 48 hours post-results.
Titagarh Rail Systems Other Announcement
Titagarh Rail Systems has filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI LODR Regulation 31.
Titagarh Rail Systems Annual General Meeting
Titagarh Rail Systems held its 29th Annual General Meeting on September 30, 2026. Shareholders approved ordinary and special business, including a final dividend of Re. 1.
Titagarh Rail Systems Merger & Restructuring Worth ₹0.5 Cr
Titagarh Rail Systems is forming a 50:50 Joint Venture with BHEL to maintain Vande Bharat trainsets. The JV has an initial paid-up capital of ₹0.50 Crore.
- Value
- ₹0.50 Cr
Titagarh Rail Systems Merger & Restructuring
Titagarh Rail Systems and BHEL signed a Joint Venture Agreement to form a company for maintaining 80 Vande Bharat trainsets for Indian Railways.
- Execution
- 35 years
Other other announcement announcements
All →Prism Medico and Pharmacy Other Announcement
Prism Medico and Pharmacy intimated BSE and MSEI that its corporate website is updated and functional per Regulation 46. This is a routine compliance undertaking with no financial impact.
Banaras Beads Other Announcement
Banaras Beads Ltd filed its half-year related-party transaction disclosure under Listing Regulation 23(9). The filing reports routine remuneration and sitting fees to promoters and directors.
Gita Renewable Energy Other Announcement
Gita Renewable Energy intimated a change in its CIN after altering its Objects Clause. The change followed a Special Resolution at its 16th AGM.
Indian Toners & Developers Other Announcement
Indian Toners & Developers has intimated that NSE approved listing of its 5.19 crore equity shares (₹2 face value) on the NSE Mainboard effective October 30, 2026. This is an additional-exchange admission of already-issued BSE-listed shares.
Indian Phosphate Other Announcement
Indian Phosphate filed a Reg 27(2) governance non-applicability certificate for Q1 FY2027. The routine compliance filing carries no transaction or financial impact.
Neuland Laboratories Other Announcement
Neuland Laboratories notified loss of 100 share certificates by shareholder Madan Mohan Singh. The company requested issuance of an entitlement letter in lieu of the lost certificates.